Wednesday, March 31, 2010

Recent US Army reliability and characterisation testing demonstrates the reliability and maturity of ECLIPSE

Recent US Army reliability and characterisation testing demonstrates the reliability and maturity of ECLIPSE
March 31, 2010

The results of recent US Government reliability and characterisation tests have demonstrated the maturity of the latest infrared countermeasure system jointly developed by SELEX Galileo and Northrop Grumman Corporation.

The ECLIPSE pointer tracker provides a low risk approach to protecting the US Army’s fixed and rotary wing fleet from surface to air missile threats. The benefit, experience and lessons learned from over 20 years of aircraft protection have influenced the design and development of this 5th generation, lightweight, low cost pointer tracker. With low mass, low power, minimal airstream intrusion and a predicted MTBF greater than 3,000 hours, ECLIPSE offers an ideal solution for the CIRCM programme.

SELEX Galileo and Northrop Grumman have a proven track record of meeting Urgent Operational Requirements and Quick Reaction Contracts. With a flexible, established and proven manufacturing and support capacity, SELEX Galileo has successfully produced and supported over 1200 pointer trackers to date.

SELEX Galileo supports existing DIRCM pointer trackers through facilities in both the US at Hurlburt Field, Florida and in the UK at Edinburgh, Scotland. With tens of thousands of DIRCM pointer tracker operational hours accrued and many years of support contracting experience, the partnership has the ability and flexibility to support any end customer’s logistical needs.

“We are confident that our experienced partnership with Northrop Grumman can meet the Army’s programme and delivery timescales. The ECLIPSE pointer tracker is ideally placed to provide a low risk, low-cost DIRCM capability for the US Army platforms,” said Alastair Morrison, Senior Vice President, Radar and Advanced Targeting at SELEX Galileo

Technorati Tags:
,



No comments:

Post a Comment